The verified answer
As of Sep 2026, DEPLOY verifies NeuroPace: 1 model, 3 deployments across 3 regions. 1 source back the record.
CategoryBiometric wearables
Overview
NeuroPace (NASDAQ: NPCE) is a Mountain View-based medical device company that developed the RNS System, the only FDA-approved brain-responsive neuromodulation device for treating drug-resistant focal epilepsy. Over 8,000 patients implanted. FY2025 revenue: 00M (25% YoY growth). 230+ Level 4 Comprehensive Epilepsy Centers in the US.
Verified record
- Verified deployments
- 3 deployments on file
- Active incidents
- None on file
Key facts
FDA
Product
Indication
Type
Data & sources
Web sources
1
1 source backing this record.View all →
Models (1)
View all models →Partnerships
Every company NeuroPace has built with, alongside the ones only announced in a press release.
NeuroPace on the deployment map
View the global map3 verified deployments across 3 regions, newest verified Jun 2024. Explore where NeuroPace's robots are operating, by place and type.
- operationalRNS System at United States (comprehensive epilepsy centers) →Pennsylvania · verified Jun 2024
- operationalRNS System at Los Angeles, California, USA →West Coast · verified Dec 2013
- operationalRNS System at United States (comprehensive epilepsy centers nationwide) →United States · verified Nov 2013
View the full NeuroPace deployment record →
Relationships
Current leadership (1)
- Joel Becker CEOsecondary-verified
Safety record
No incidents on record for NeuroPace.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Operator customers (1)
- NeuroPace3 deployments
Recent coverage
NeuroPace in third-party press
Peer companies
- Google21 models
- Samsung Electronics4 models
- Butterfly Network2 models
- Abbott1 model
- Apple1 model
- Blackrock Neurotech1 model
Financial state
- Reporting basis
- sec_10k
- Lifecycle stage
- growth
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Partnerships
2 total · 2 operating
Every company NeuroPace has built with, alongside the ones only announced in a press release.
All 2 partnerships
open in the atlas →- neuropace x nvidiawithNVIDIA1109technology—operating
- neuropace x awswithAWS976technology—operating
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdAug 8, 2026
Added to the verified registry
- Deployment verifiedVerifiedJun 1, 2024
RNS System at United States (comprehensive epilepsy centers)
- Deployment verifiedVerifiedDec 1, 2013
RNS System at Los Angeles, California, USA
- Deployment verifiedVerifiedNov 1, 2013
RNS System at United States (comprehensive epilepsy centers nationwide)
Sources (1)
Common questions
What is NeuroPace?
What does NeuroPace make?
Is NeuroPace publicly traded?
Who competes with NeuroPace?
Who is the CEO of NeuroPace?
How can I invest in NeuroPace?
Where is NeuroPace headquartered?
Who owns NeuroPace?
Where does NeuroPace operate robots?
How many robots has NeuroPace deployed?
Is NeuroPace a top robotics company?
Is NeuroPace safe?
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-21
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-08-21
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for NeuroPace.Peer companies
- Google21 models
- Samsung Electronics4 models
- Butterfly Network2 models
- Abbott1 model
- Apple1 model
- Blackrock Neurotech1 model
In the press
Recent coverage mentioning NeuroPace from third-party publications. Automatically surfaced; not part of the verified registry record.
Machine-readable surfaces
- Markdown mirror: /companies/neuropace.md
- RSS feed: /companies/neuropace/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/b553bad1-52b1-4096-b537-da7460d39812
- Revision history: /companies/neuropace/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Google21 models
- Samsung Electronics4 models
- Butterfly Network2 models
- Abbott1 model
- Apple1 model
- Blackrock Neurotech1 model
Video
Kristen Riley, MD, highlights some of the new technology being used at UAB Medicine for the surgical management of epilepsy patients, such as Stereoelectroencep
"This responsive neurostimulator is a very clever device," said Dr. Jonathan Edwards, director of MUSC's Comprehensive Epilepsy Program. The NeuroPace RNS Syst
Sonia Azad has more on an implant that can turn epilepsy patients into "a whole new person." WFAA.com
A teen with autism has a special device implanted on his brain to stop debilitating seizures. Saadi Ghatan, MD, Chair of Neurosurgery at Mount Sinai West and Mo
6 months after Neuropace/RNS surgery. Finances, hair, life. A Neuropace is an implant/ device that is put into the head and is like a pacemaker. It is to help
Welcome to living with Epilepsy! I got electrodes put in to prepare for Neuropace/RNS surgery. An implant that helps with Epilepsy (seizures). Fingers crossed
Jordan learns how to do his daily download, and what the doctor sees on his end. Since this video was made, the Neuropace has been activated and stimulates the
This will be a review of the RNS system for Epilepsy, including which patients benefit from RNS and what patients can expect from the therapy . Speakers: Pue F
I'm sleepy af.... and in a house robe and my bonnet, and do not give a damn about it. Neuropace implanted and removed in less than 3 years. More surgeries to co
This video shows how the Neuropace RNS system works for seizures. My Epileptic Life! I found an old video of me uploading my seizure info to the Neuropace RNS s
It’s like a pacemaker for the brain and the new FDA-approve Neuropace is changing the life of one woman with epilepsy
Heat Index
Serious54/100
A composite of competitive footprint, funding, press velocity, active partnerships, and supply-chain edges. Different from the Intelligence score below (which is per-form-factor productization). Non-robotics companies cap at 25.
Reality vs attention
NeuroPace draws attention at the 22nd percentile but verifies reality at the 81st percentile among biometric robots. Hype Gap -59.3, 27th widest among biometric robots.
6-month trend
Analysis
Clean safety record across 3 verified deployments. Limited public funding data for capital position assessment.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Sep 23, 2026